TABLE 1:
Patient/Age/Sex | Onset to (min) |
UK Dose (U) | Arterial lesion on DSA | Final TIMI Grade | NIHSS Score |
mRS Score 90 Day | HT | ||
---|---|---|---|---|---|---|---|---|---|
rTPA | DSA | Baseline | 30 Day | ||||||
1/59/F | 120 | 270 | 800,000 | Distal ICA | 2 | 9 | 5 | 2 | No |
2/61/M | 210 | 290 | 800,000 | BA | 3 | 28 | 1 | 0 | No |
3/53/F | 60 | 120 | 500,000 | M1 | 3 | 14 | 2 | 1 | No |
4/74/F | 195 | 300 | 300,000 | M2 | 0 | 22 | 0 | 0 | Asym |
5/76/F | 170 | 260 | 500,000 | M1 | 3 | 13 | 1 | 0 | No |
6/82/M | 100 | NA | NA | NA | NA | 30 | 0 | 0 | No |
7/62/M | 75 | 110 | 700,000 | M1 | 3 | 25 | 3 | 1 | No |
8/60/F | 90 | 160 | 600,000 | M1 | 2 | 19 | 10 | 4 | Asym |
9/52/M | 90 | 160 | NA | M1 stenosis | 3 | 8 | 0 | 0 | No |
10/47/M | 90 | 60* | 800,000 | BA | 3 | 15 | 0 | 0 | No |
11/48/M | 130 | 210* | NA | Normal | 3 | 7 | 2 | 0 | No |
12/78/M | 175 | NA | NA | NA | NA | 9 | NA | 6 | No |
13/74/F | 120 | 240 | 800,000 | M1 | 3 | 17 | 7 | 3 | Asym |
14/65/F | 150 | 210 | 400,000 | Distal ICA | 0 | 22 | 25 | 5 | Asym |
15/63/M | 145 | 210 | 800,000 | M1 | 3 | 22 | 7 | 2 | No |
16/61/M | 140 | NA | NA | NA | NA | 7 | 1 | 1 | No |
17/78/M | 105 | 205 | NA | Cervical ICA | 0 | 19 | NA | 5 | No |
18/70/M | 150 | 270 | 600,000 | M1 | 2 | 23 | 9 | 2 | No |
19/81/M | 130 | 230 | NA | Distal ICA stenosis | 3 | 23 | 2 | 1 | No |
20/67/M | 130 | NA | NA | NA | NA | 4 | 30 | 6 | Sym |
21/71/F | 70 | 160 | 1,000,000 | Distal ICA | 1 | 23 | NA | 6 | Sym |
22/59/F | 170 | 290 | NA | Normal | 3 | 21 | 1 | 1 | No |
23/80/M | 160 | NA | NA | NA | NA | 16 | 4 | 1 | No |
24/60/F | 170 | 310 | 500,000 | M1 | 0 | 17 | 15 | 4 | Asym |
25/59/M | 110 | 230 | NA | Cervical ICA | 0 | 22 | NA | 2 | No |
26/54/M | 150 | 275 | 500,000 | Distal ICA | 3 | 20 | 4 | 1 | No |
27/72/F | 150 | 255 | NA | PCA | 0 | 17 | 3 | 1 | No |
28/58/F | 180 | 265 | 500,000 | M1 | 3 | 13 | 0 | 0 | No |
29/57/M | 135 | NA | NA | NA | NA | 8 | 1 | 1 | No |
30/81/M | 150 | 250 | NA | BA stenosis | 3 | 24 | 1 | 1 | No |
Note.—Asym indicates asymptomatic hemorrhagic transformation; DSA, digital subtraction angiography; M1, M1 segment of the MCA; M2, M2 segment of the MCA; NA, not applicable; and Sym, symptomatic hemorrhagic transformation.
Time from recurrent symptoms after IV thrombolysis to angiography.